| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Becton Dickinson posts Q4 earnings beat, raises FY26 EPS outlook, with strong growth in Medical and Interventional segments des...
Becton Dickinson (NYSE:BDX) is looking for FY2026 Adj EPS of $14.75-$15.05 vs $14.38 analyst estimate..
Becton, Dickinson (NYSE:BDX) reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.92 ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the i...
BD (Becton, Dickinson and Company) (NYSE: BDX) a leading global medical technology company, today announced it has received U.S.
BD (Becton, Dickinson and Company) (NYSE:BDX), a global leader in medical technology, introduces the BD Incada™ Connected Care ...